Document is current
Any future updates will be listed below
-
Authors
Ishiuchi, Naoki
Nakashima, Ayumu
Doi, Shigehiro
Yoshida, Ken
Maeda, Satoshi
Kanai, Ryo
Yamada, Yumi
Ike, Takeshi
Doi, Toshiki
Kato, Yukio
Masaki, Takao
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP17K09699)
- License Information
-
More Information
Article History
Received: 1 November 2019
Revised: 12 February 2020
Accepted: 10 March 2020
First Online: 20 March 2020
Ethics approval and consent to participate
: All experimental procedures were approved by the Institutional Animal Care and Use Committee of Hiroshima University (permit number, A16-83).
: Not applicable.
: The Department of Stem Cell Biology and Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University, is a collaborative research laboratory funded by TWOCELLS Company, Limited. Dr. Maeda is the deputy division manager of R&D Division II, Head Office of Research and Development of TWOCELLS Company, Limited. Emeritus Prof. Kato is the vice president of TWOCELLS Company, Limited. Except for the abovementioned disclosures, all authors have declared that no conflict of interest exists.
